Oral Medicine & Oral Cancer Group

Joint Lab Head
A/Prof Antonio Celentano and
Dr Tami Yap

Research Overview

The Oral Medicine and Oral Cancer Group undertakes extensive studies of oral mucosal disease, particularly in relationship to the early recognition and development of oral cancer. Oral potentially malignant disorders are studied using novel models, treatment, and diagnostic precision for the prevention and treatment of oral mucosal disease. In parallel, the group investigates the early molecular events driving the onset of oral mucosal diseases, including oral autoimmune, inflammatory, and malignant conditions. Our research aims to develop novel mechanism-based prevention and/or treatment strategies for these diseases. Our team expertise includes in silico, in vitro, in vivo and clinic to lab translational expertise with diverse expertise in application of molecular analyses.